Contribution of genetic and nutritional factors to DNA damage in heavy smokers

Abstract

Prior epidemiological evidence suggests that genes controlling the metabolism of carcinogens and antioxidant/nutritional status are associated with lung cancer risk, possibly through their ability to modulate DNA damage by carcinogens. We performed a cross-sectional analysis of 159 heavy smokers from a cohort of subjects enrolled in a smoking cessation program. A total of 159 blood samples were analyzed to determine the relative contributions of genetic polymorphisms [CYP1A1 MspI and exon 7 and glutathione S-transferase M1 (GSTM1)] and plasma micronutrients to polycyclic aromatic hydrocarbon-DNA (PAH-DNA) adduct levels. DNA damage in smokers was affected by genetic polymorphisms and nutritional status. Smokers with the CYP1A1 exon 7 valine polymorphism had significantly higher (2-fold, P ≤ 0.03) levels of DNA damage than those without. In parallel models, PAH-DNA adducts were inversely associated with plasma levels of retinol (β = -0.93, P = 0.01), β-carotene (β = -0.18, P = 0.09), and α-tocopherol (β = -0.28, P = 0.21) in 159 subjects. The association between smoking-adjusted plasma p-carotene levels and DNA damage was only significant in those subjects lacking the GSTM1 detoxification gene (β = -0.30, P = 0.05, n = 75). There was a statistical interaction between β-carotene and α-tocopherol; when β-carotene was low α-tocopherol had a significant protective effect (β = -0.78, P = 0.04) on adducts, but not when β-carotene was high (β = -0.16, P = 0.57). Plasma α-tocopherol was significantly correlated with β-carotene (r = 0.36, P = 0.0005) and less strongly with retinol (r = 0.20, P = 0.0005). These results suggest that several micronutrients may act in concert to protect against DNA damage and highlight the importance of assessing overall antioxidant status. In conclusion, a subset of smokers may be at increased risk of DNA damage and possibly lung cancer due to the combined effect of low plasma micronutrients and genetic susceptibility factors. The use of biological markers to assess efficacy of interventions and to study mechanisms of micronutrients is timely given the current debate regarding the use of chemopreventive agents in high risk populations.